Mycostatin and Protein total decreased for Men aged 50-59 (a phase IV clinical study of FDA data)
Summary:
Protein total decreased is found for men aged 50-59 who take Mycostatin (nystatin). This study is created by eHealthMe based on reports of 270 men aged 50-59 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:
- Time on Mycostatin when people have Protein total decreased
- Top conditions
- Top co-used drugs
- Top other side effects
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
270 men aged 50-59 reported to have side effects when taking Mycostatin.
Among them, 1 person (0.37%) has Protein total decreased
What is Mycostatin?
Mycostatin has active ingredients of nystatin. eHealthMe is studying from 4,144 Mycostatin users. Check the latest studies of Mycostatin.
What is Protein total decreased?
Protein total decreased is found to be associated with 723 drugs and 933 conditions by eHealthMe. Check the latest studies of Protein total decreased.
Number of reports submitted per year:

Severity of Protein total decreased
n/aHow people recovered from Protein total decreased
n/aTop conditions involved for these people *:
You may use this to check any potential undetected conditions.
- Secondary Hypothyroidism (pituitary gland and its failure to secrete tsh): 1 person, 100.00%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 100.00%
- Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 1 person, 100.00%
Top co-used drugs for these people *:
You may use this to check any potential interacting drugs.
- Zofran: 1 person, 100.00%
- Zithromax: 1 person, 100.00%
- Vfend: 1 person, 100.00%
- Ultram: 1 person, 100.00%
- Tylenol: 1 person, 100.00%
- Synthroid: 1 person, 100.00%
- Protonix: 1 person, 100.00%
- Prograf: 1 person, 100.00%
- Pregnyl: 1 person, 100.00%
- Jakafi: 1 person, 100.00%
Top other side effects for these people *:
You may use this to check any potential undetected side effects.
- Weight Increased: 1 person, 100.00%
- Weight Decreased: 1 person, 100.00%
- Bk Virus Infection: 1 person, 100.00%
- Blood Albumin Decreased: 1 person, 100.00%
- Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 1 person, 100.00%
- Diarrhea: 1 person, 100.00%
- Dry Skin: 1 person, 100.00%
- Epstein-Barr Viraemia: 1 person, 100.00%
- Fluid Overload (too much fluid in the blood): 1 person, 100.00%
- Haemorrhage Urinary Tract (bleeding from uterine): 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Mycostatin and have Protein total decreased?
- Check whether Protein total decreased is associated with a drug or a condition- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies:
How the study uses the data?
The study is based on (applicable) gender, age, nystatin (the active ingredients of Mycostatin) and Mycostatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Bronchitis and drugs of ingredients of memantine hydrochloride - 4 seconds ago
- Stress And Anxiety in Methylin, how severe and when it was recovered? - 5 seconds ago
- Epidermal Necrolysis and drugs of ingredients of heparin sodium - 10 seconds ago
- Tagamet and Losartan drug interactions for men aged 60+ - 17 seconds ago
- Could Spironolactone cause Renal Injury? - 20 seconds ago
- Could Prednisone cause Injection Site Discoloration? - 21 seconds ago
- Drug interactions of Zestril and Caffeine Citrate - 24 seconds ago
- Monopril-Hct vs. Dynacirc Cr, side effect and effectiveness comparison - 49 seconds ago
- Drug interactions of Tracleer and Ibu - 50 seconds ago
- Renal Neoplasm and drugs of ingredients of insulin aspart recombinant - 51 seconds ago